| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/17/2002 | CN1358516A Traditional Chinese medicine for treating rheumatism |
| 07/17/2002 | CN1087740C New benzimidzole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CN1087625C Traditional Chinese medicine preparation for treating colitis |
| 07/16/2002 | US6420600 Hydroxyalkylphenyldiamides |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420567 Prodrugs |
| 07/16/2002 | US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420431 Methods for treating disordered tissue through agitated delivery of anti-infective compositions |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420395 Disorders or diseases involving the cholinergic system of the central nervous system, pain, inflammatory diseases, diseases caused by smooth muscle contractions and as assistance in the cessation of chemical substance abuse. |
| 07/16/2002 | US6420394 Topically applied pharmaceutical formulation |
| 07/16/2002 | US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420382 Tyrosine kinase inhibitors |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6420188 Screening assay for the identification of inhibitors for macrophage migration inhibitory factor |
| 07/16/2002 | US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents |
| 07/16/2002 | US6419950 Extracts of zanthoxylum bungeanum, and pharmaceutical and cosmetic formulations containing same |
| 07/16/2002 | US6419929 Genetic engineering |
| 07/16/2002 | US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 07/16/2002 | CA2286296C Inhibitors for urokinase receptor |
| 07/16/2002 | CA2165519C P substance antagonist used for the treatment of itching, ocular and/or palpebral algia and ocular and/or palpebral dysesthesia |
| 07/16/2002 | CA2131383C Wound healing and treatment of fibrotic disorders |
| 07/16/2002 | CA2116956C Pharmaceutical process |
| 07/16/2002 | CA2050875C 3-(1h-indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053737A1 Nf-kb activating gene |
| 07/11/2002 | WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | WO2002053700A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | WO2002053580A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists |
| 07/11/2002 | WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 07/11/2002 | WO2002053534A1 Vla-4 inhibitors |
| 07/11/2002 | WO2002053523A1 Tropolone derivative |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |
| 07/11/2002 | WO2002053516A2 N(phenylsulphonyl)glycine derivatives and their therapeutic use |
| 07/11/2002 | WO2002053191A1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 07/11/2002 | WO2002053188A1 Compositions comprising cyclodextrins and no-releasing drugs |
| 07/11/2002 | WO2002053185A2 Anti-inflammatory use of polycationic compounds |
| 07/11/2002 | WO2002053175A2 Use of botulinum toxin for treatment of articular pathologies |
| 07/11/2002 | WO2002053150A1 Preventives for wound adhesion |
| 07/11/2002 | WO2002053149A2 Medicament containing a polyamine as an active substance |
| 07/11/2002 | WO2002053130A2 Sustained release drug delivery devices with coated drug cores |
| 07/11/2002 | WO2002053110A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | WO2002053100A2 Pharmaceutical dosage form for oral administration of low molecular weight heparin |
| 07/11/2002 | WO2002034705A3 C-nitroso compounds and use thereof |
| 07/11/2002 | WO2002032446A3 Use of neutrophil inhibitory factor in combination with other thrombolytic or neuroprotective drugs for treating pathophysiological conditions involving neutrophils |
| 07/11/2002 | WO2002028480A3 Methods of therapy for b-cell malignancies |
| 07/11/2002 | WO2002028349A3 Method of treating cancer using dithiocarbamate derivatives |
| 07/11/2002 | WO2002024658A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002024657A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002017914A8 Fused pyrrolocarbazoles against inflammation |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002011666A3 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008221A3 Capsaicin receptor ligands |
| 07/11/2002 | WO2001096311A3 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 07/11/2002 | WO2001077377A3 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 07/11/2002 | WO2001076556A3 Lipid-based drug delivery systems against parasitic infections |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001025438A3 Ifn-alpha homologues |
| 07/11/2002 | WO2001024785A3 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 07/11/2002 | WO2001021213A3 Inhibition of secretion from non-neuronal cells |
| 07/11/2002 | WO2001020969A3 Use of ribose to prevent cramping and soreness in muscles |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | WO2000075144A9 Peroxynitrite decomposition catalysts and methods of use thereof |
| 07/11/2002 | WO2000073321A9 Human tumor necrosis factor receptor tr10 |
| 07/11/2002 | WO2000062067A9 Novel transduction molecules and methods for using same |
| 07/11/2002 | WO2000061231A3 Medical use |
| 07/11/2002 | US20020091272 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/11/2002 | US20020091270 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 07/11/2002 | US20020091265 4-phenyl-pyridine derivatives |
| 07/11/2002 | US20020091251 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 07/11/2002 | US20020091240 Humanized antibodies to gamma-interferon |
| 07/11/2002 | US20020091236 Nucleotide sequences coding preferential polypeptide for use in detection of bactericides |
| 07/11/2002 | US20020091153 Novel anandamide amidase inhibitors as analgesic agents |
| 07/11/2002 | US20020091147 Substituted-phenyl ketone derivatives as ip antagonists |
| 07/11/2002 | US20020091143 Use of 4-substituted tetrahydropyridines for the manufacture of medicament s acting upon TGF-beta 1 |
| 07/11/2002 | US20020091130 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 07/11/2002 | US20020091115 Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
| 07/11/2002 | US20020091113 Treatment of septic shock |
| 07/11/2002 | US20020091108 Stable salts of O-acetylsalicylic acid with basic amino acids |
| 07/11/2002 | US20020091105 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 07/11/2002 | US20020091104 Protein tyrosine phosphatases inhibitors, especially as antidiabetic agents |
| 07/11/2002 | US20020091093 Treating, preventing, or inhibiting diseases and disorders associated with inflammation, cell-proliferation |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |
| 07/11/2002 | US20020090724 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 07/11/2002 | US20020090703 Mammalian protein phosphatases |
| 07/11/2002 | US20020090658 Diagnosing connective tissue defects; obtain sample, screen sample for the presence of degradation protein, amplified concentrations of protein indicate connective tissue defects |
| 07/11/2002 | US20020090406 Tahitian noni juice on COX-1 and COX-2 and tahitian noni juice as a selective COX-2 inhibitor |